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Complications and management of hepatic arterial infusion 
chemotherapy for 79 patients with liver metastasis were 
studied. Complications were observed in 20 cases (25.3%), 
who included 8 cases (88.9%) of lapalotomy group and 12 
cases (17.6%) of left subclavian group. In lapalotomy 
group, they were 5 cases of system occlusion, 2 cases of 
catheter tip dislocation and catheter reinsertion through the 
left subclavian artery was performed in 4 cases. In left 
subclavian group, they were 4 cases of system occlusion, 3 
cases of catheter tip dislocation, 2 cases of hepatic arterial 
occlusion and hepatic arterial infusion chemotherapy was 
continued with catheter reinsertion in 8 of the 9 cases. It 
was considered that positive anti-complication measures 
including catheter reinsertion would contribute to the im-
provement of therapeutic results.
Results 
Complications were observed in 8/9 cases (88.9%) of the 
laparotomy group. They were 5 cases of system occlusion, 
2 cases of catheter tip dislocation and 1 case of gastric 
ulcer. On the other hand, complications were observed in 
12/68 cases (17.6%) of the left subclavian artery method 
group. There were 4 cases of system occlusion, 3 cases of 
catheter tip dislocation, 2 cases of hepatic artery occlusion, 
2 cases of cerebral infarction and 1 case of gastric ulcer. 
The complications occurred early in the laparotomy group 
and those in the left subclavian artery method group, 
occurring within 6 months. Hepatic artery occlusion oc-
curred in no less than 1 year (Table 1).
Table 1. Complications of hepatic arterial infusion chemotherapy 
by infusional port
Introduction 
The progress and development of an infusional port and 
catheter with a knot (Anthron tube) was a great step for-
ward in the hepatic arterial infusion chemotherapy (HAIC) 
for liver metastasis to avoid the reduction of QOL. The 
favorable effect of HAIC has been reported by using infu-
sional port and catheter with a knot. On the other hand, a 
high rate of complications on the system or hepatic artery 
has led to discontinuance of HAIC. We have studied the 
complications and their managements on HAIC for meta-
static liver tumors.
Subjects 
Seventy-nine patients with liver metastasis who had been 
treated by HAIC between April 1991 and March 1993 were 
selected for this study. The subjects consisted of 44 patients 
with colorectal cancer, 16 with ' gastric cancer, 6 with 
pancreas cancer, 3 with breast cancer, 3 with lung cancer 
and 7 with the other cancers. The route of catheter insertion 
was laparotomy in 9 patients, left subclavian method in 68 
and femoral method in 2.
     Complication Laparotomy Left subclavian                         (n = 9) method (n = 68) 
system occlusion 5 ( 2.6 ± 2.1 )* 4 ( 6.3 ± 3.5) 
catheter dislocation 2 (0.75 ± 0.25) 3 ( 5.2 ± 2.3) 
occlusion of hepatic artery 2 (13.7 ± 2.7) 
cerebral infarction 2 ( 6.5 ± 0.5) 
gastric ulcer 1(12.0) 1 ( 7.0) 
                   8/9 [88.9%] 12/68 [17.6%] 
*: (mean ± SD months) complication free interval
 Arterial infusion port indwelling was performed in the 9 
cases by the laparotomy method. HAIC was continued with 
catheter reinsertion thorough the left subclavian artery in 3 
of the 5 system occlusion cases and 1 of the 2 catheter tip 
dislocation cases. Right gastric artery embolization with a 
metallic coil allowed continued HAIC performance in the 1 
case of gastric ulcer (Table 2). 
 Complications observed in the left subclavian artery 
method group included 4 cases of system occlusion that 
occurred in 1.4-11.0 (mean:6.4) months. The system occlu-
sion in case 2 was considered attributable to catheter 
occlusion, and the occlusion was removed with guide wire 
manipulation alone in this case. Catheter reinsertion
Table 2. Effects and Complications of arterial infusion chemotherapy by laparotomy
Case Age Sex Complication Periods Management Effects Prognosis 
 1 58 M system occlusion 4M reinsertion PD 8M death 
 2 55 F dislocation I M 15M death 
 3 53 F system occlusion 40D reinsertion PD 7M death 
 4 74 F system occlusion 14D 23M alive 
 5 65 M system occlusion 6M 22M alive 
 6 77 M gastric ulcer 12M RGA embolus PR 19M alive 
 7 54 M system occlusion 40D reinsertion PR 6M alive 
 8 57 M dislocation 12D reinsertion PR 18M alive 
 9 67 M (-) 15M alive
through the left subclavian artery or femoral artery was 
performed in the other cases. As for the prognosis, case 3 
died of lung metastasis at month 9 and 3 other cases have 
survived for 12-17 months (Table 3).
Table 3. Complications of arterial infusion chemotherapy via left 
subclavian artery I (system occlusion)
Case Age Sex Periods Management Prognosis 
 1 72 M 5.7M reinsertion 16M alive 
 2 81 M 11.OM recanalization 17M alive 
                       using guide wire 
 3 53 M 7.4M reinsertion 9M death* 
 4 68 M 1.4M reinsertion 12M alive 
*: lung metastasis
 Catheter tip dislocation complication was found in 3 
cases of this group in 2.0-7.3 (mean:5.2) months. The 
catheter tip was found inserted deep into the splenic artery, 
aorta and right hepatic artery. Catheter reinsertion was 
performed in Cases 5 and 6, while the left subclavian 
wound was incised to withdraw the catheter and have it 
indwelled in the correct position in Case 7. As for the 
prognosis, Case 7 died of lung metastasis at month 4 and 
the other cases have been surviving for 12-14 months 
(Table 4).
 Hepatic artery occlusion occurred in 2 cases of this 
group in 11.0-16.3 months. Catheter reinsertion beyond the 
occluded region was performed using a guide wire in Case 
8. Lung metastasis intensified in Case 9 and hepatic arterial 
infusion was discontinued and switched to systemic chemo-
therapy in this case. Cerebral infarction occurred in 2 cases 
of this group in 6.0-11.0 months. Both cases had infarction 
in the carebellum and showed Wallenberg symptoms. The 
symptoms were improved with anticoagulant therapy in 
both cases (Table 5).
Discussion 
The therapeutic results of arterial infusion chemotherapy 
for metastatic liver cancer have improved drastically with 
the permeation of subcutaneous implantation type arterial 
infusion port and antithorombotic catheter procedures. Arai 
et al. reported 73% direct effect of weekly high dose 5FU 
hepatic arterial infusion obtained in liver metastasis from 
colorectal cancers" and 76.5% response rate obtained with 
FAM arterial infusion in liver metastasis from gastric 
cancers. 2) On the other hand, however, cases of inevitable 
discontinuation of arterial infusion therapy were experi-
enced because of the complications particular to arterial 
infusion such as system occlusion and catheter tip dislo-
Table 4. Complications of arterial infusion chemotherapy via left subclavian artery 11 (dislocation)
 Case Age Sex Periods Catheter tip Position Management Prognosis 
   5 71 F 6.3M splenic artery reinsertion 12M death 
   6 71 M 7.3M aorta reinsertion 14M alive 
   7 53 M 2.OM right hepatic artery reinsertion 4M death 
*: lung metastasis
Table 5. Complications of arterial infusion chemotherapy via left subclavian artery III (hepatic arterial occlusion and carebral infarction)
  Case Age Sex Periods Management Prognosis 
hepatic arterial occlusion 
   8 65 F 16.3M reinsertion 20M alive 
   9 57 M 11.OM systemic chemotherapy 18M alive 
cerebral infarction 
  10 58 F 6.OM anticoagulant therapy 9M alive 
  11 72 M 1 I.OM anticoagulant therapy 16M alive
cation. 
  In the present clinical study, complications were ob-
served in 20 (25.3%) of the 79 cases that received arterial 
infusion port insertion. Analysis of complications by the 
insertion routes revealed a high complication incidence of 
8/9 cases in the laparotomy group. This was considered 
attributable to that most of the early cases received lapa-
rotomy resulting in unfamiliarity with system insertion and 
management. Other factors considered attributable were the 
use of silicon catheters in the system and consequent 
anticoagulability problems. On the other hand, compli-
cations occurred in 12/68 cases (17.6%) of the left subcla-
vian artery method group. The incidence was slightly lower 
than the 24% reported by Kasuya et al." Therefore, the 
complication in the left subclavian artery method group 
were examined in detail. System occlusion complications 
occurred in 4 cases in an average of 6.3 months. Catheter 
reinsertion through the left subclavian artery or femoral 
artery was possible in all of these cases. Catheter tip 
dislocation occurred in 3 cases in an average of 5.2 months. 
The catheter tip dislocation sites ranged from the splenic 
artery to the aorta and right hepatic artery periphery. 
Different from system occlusion, abnormality is rarely 
noticed during drug infusion in the case of catheter tip 
dislocation. Therefore, regular checking of catheter posi-
tion and determination of therapeutic effects were consid-
ered imperative to early detection. Hepatic artery occlusion 
complications were observed in 2 cases. These were on 
long-term arterial infusion therapy for an average of 13. 7 
months. Hepatic artery occlusion is considered to be in-
duced by causes such as chemical injury of the endangium
due to drug infusion and physical damage of the endan-
gium due to catheterization. Once hepatic artery occlusion 
occurs, there is no effective measure for its correction. 
Therefore, this was considered the utmost problem with the 
perfomance of long-term arterial infusion therapy. Arai et 
al reported a decrease in the incidence of hepatic artery 
occlusion obtained with CHA or SPA coil method in place 
of the conventional standard catheter indwelling method. 
These methods including catheter indwelling method were 
considered to be subjects for future research. 
 The success rates reported on arterial infusion therapy 
for metastatic liver cancer vary widely from 10%-75%. 
This is considered largely due to technical differences. 
Moreover, since the incidence of complications particular 
to arterial infusion rises in long-term arterial infusion cases, 
it was considered that positive anti-complication measures 
including catheter reinsertion would contribute to the im-
provement of therapeutic results.
References 
1) Arai Y, Sone Y, Tohyama N et al: Five-hour hepatic arterial infusion of 
  hight-dose 5FU on weekly schedule for liver metastasis from colorectal 
  cancer, Jpn J Cancer Chemother. 18, 1869-1872, 1991. 
2) Arai Y, Kido C, Endo T et al: 5FU/ADR/MMC combined hepatic 
  infusion for liver metastasis from gastric cancer, Jap J Cancer Che-
  mother. 15, 2433-2436, 1988. 
3) Kasuya K, Kimura K, Koyanagi Y et al: Complication and its manage-
  ment of hepatic arterial infusion chemotherapy, J Jpn Soc Cancer ther. 
  27.     278, 1992.
